Cargando…
TDP-43, a protein central to amyotrophic lateral sclerosis, is destabilized by tankyrase-1 and -2
In >95% of cases of amyotrophic lateral sclerosis (ALS) and ∼45% of frontotemporal degeneration (FTD), the RNA/DNA-binding protein TDP-43 is cleared from the nucleus and abnormally accumulates in the cytoplasm of affected brain cells. Although the cellular triggers of disease pathology remain eni...
Autores principales: | McGurk, Leeanne, Rifai, Olivia M., Bonini, Nancy M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Company of Biologists Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7328137/ https://www.ncbi.nlm.nih.gov/pubmed/32409565 http://dx.doi.org/10.1242/jcs.245811 |
Ejemplares similares
-
Therapeutic modulation of eIF2α-phosphorylation rescues TDP-43 toxicity in amyotrophic lateral sclerosis disease models
por: Kim, Hyung-Jun, et al.
Publicado: (2013) -
Poly(ADP-ribose) Engages the TDP-43 Nuclear-Localization
Sequence to Regulate Granulo-Filamentous Aggregation
por: McGurk, Leeanne, et al.
Publicado: (2018) -
TDP-43 protein variants as biomarkers in amyotrophic lateral sclerosis
por: Williams, Stephanie M., et al.
Publicado: (2017) -
TDP-43—The key to understanding amyotrophic lateral sclerosis
por: Xu, Zuoshang, et al.
Publicado: (2014) -
The role of TDP-43 mislocalization in amyotrophic lateral sclerosis
por: Suk, Terry R., et al.
Publicado: (2020)